New pyrimidine compounds may lead to improved treatments for childhood brain cancer

Links shared publicly online about this topic.

  • 1,260
    total visits

New pyrimidine compounds may lead to improved treatments for childhood brain cancer

physorg.com —

Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.

View full resource at physorg.com

Tags: Brain, Cancer, Brain Cancer, Brain Tumor, Children's Health

  • Share

Most Recently Shared on April 6, 2010 at 7:36 pm By:

FightCancer FightCancer

New pyrimidine compounds may lead to improved treatments for childhood brain cancer http://bit.ly/bTJLBh

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

PhysOrg Health News PhysOrg Health News

New pyrimidine compounds may lead to improved treatments for childhood brain cancer

sciencedaily.com — “Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. A recent study shows that pyrazolo-[3,4-d]--pyrimidine-derivatives, designed to target Src, may be effective in interfering with the cell cycle and causing cancer cell death in medulloblastoma.” View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on April 6, 2010 at 3:30 pm By:

sciencedaily sciencedaily Health News

New pyrimidine compounds may lead to improved treatments for childhood brain cancer: Src (short for sarcoma) is a ... http://bit.ly/cDVYOE

2 years ago...

Reply

Retweet

Favorite

Advertisement